Clearmind completes Part A of Phase I/II trial for alcohol disorder drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. AAPL
4. ACN
5. IONS
6. AZN
7. ROIV
8. HOOD
9. QCOM
10. NVDA

Go back to Clearmind completes Part A of Phase I/II trial for alcohol disorder drug
(NASDAQ: CMND) Delayed: 0.99 -0.17 (14.66%)
Previous Close $1.16    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.15    P/E N/A 
Day Low $0.92    EPS $ 
Volume 2,045,617